Creative Medical Technology Holdings (CELZ) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Creative Medical Technology Holdings (CELZ) over the last 9 years, with Q3 2025 value amounting to -$0.48.
- Creative Medical Technology Holdings' EPS (Weighted Average and Diluted) rose 3600.0% to -$0.48 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.25, marking a year-over-year increase of 2469.88%. This contributed to the annual value of -$3.71 for FY2024, which is 119.53% up from last year.
- According to the latest figures from Q3 2025, Creative Medical Technology Holdings' EPS (Weighted Average and Diluted) is -$0.48, which was up 3600.0% from -$0.48 recorded in Q2 2025.
- Creative Medical Technology Holdings' EPS (Weighted Average and Diluted)'s 5-year high stood at $11.18 during Q1 2021, with a 5-year trough of -$1.25 in Q4 2024.
- Its 5-year average for EPS (Weighted Average and Diluted) is $0.2, with a median of -$0.52 in 2022.
- The largest annual percentage gain for Creative Medical Technology Holdings' EPS (Weighted Average and Diluted) in the last 5 years was 22885566.51% (2021), contrasted with its biggest fall of 1240000.0% (2021).
- Over the past 5 years, Creative Medical Technology Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at -$1.19 in 2021, then soared by 52.34% to -$0.57 in 2022, then tumbled by 109.73% to -$1.19 in 2023, then decreased by 5.02% to -$1.25 in 2024, then surged by 61.67% to -$0.48 in 2025.
- Its last three reported values are -$0.48 in Q3 2025, -$0.48 for Q2 2025, and $0.83 during Q1 2025.